NEWS
- 25 March | The Honest UPSC Talk Nobody Tells You Click Here to see Abhijit Asokan AIR 234 talk →
- 10 March | SFG Folks! This dude got Rank 7 in CSE 2025 with SFG! →
- 10 March | SFG Folks! She failed prelims 3 times. Then cleared the exam in one go! Watch Now! →
News: India has started the clinical trials of Covid-19 vaccine – ZyCoV-D.
Facts:
- ZyCoV-D: It is a plasmid DNA vaccine designed and developed by Zydus, a pharmaceutical company.
- The vaccine comes under the Vaccine Discovery Programme supported by the Department of Biotechnology under the National Biopharma Mission.
Additional Facts:
- National Biopharma Mission(NBM): It is an Academia-Industry Collaborative Mission for Accelerating Discovery Research to Early Development for Biopharmaceuticals.
- Launched Year: It was launched in 2017 at a total cost of Rs 1500 crore and is 50% co-funded by World Bank loan.
- Objective: To enable and nurture an ecosystem for preparing India’s technological development capabilities in biopharmaceuticals including vaccines, medical devices and diagnostics to a level that will be globally competitive over the next decade.
- Implementation: Biotechnology Industry Research Assistance Council (BIRAC).
- Innovate in India(i3) Programme: Under this Mission, the Government has launched Innovate in India(i3) programme to create an enabling ecosystem to promote entrepreneurship and indigenous manufacturing in the biopharma sector.
